Featured Products
Our Promise to You
Guaranteed product quality, expert customer support
ONLINE INQUIRY
SKG-II-SF
Cat.No.: CSC-C6464J
Species: Human
Morphology: epithelial-like
Culture Properties: Adherent cells
- Specification
- Q & A
- Customer Review
Store in liquid nitrogen.
Targeted therapies for uterine/cervix tumor cells have seen advancements in recent years. For example, the use of immune checkpoint inhibitors, such as pembrolizumab, has shown promising results in certain cases of advanced or recurrent uterine/cervix cancers. Additionally, targeted therapies that inhibit specific molecular pathways, such as inhibitors of the PI3K/AKT/mTOR pathway, are being explored in clinical trials.
Ask a Question
Average Rating: 4.0 | 1 Scientist has reviewed this product
An excellent choice
I've been using this cell product for regenerative medicine research, and it has proven to be an excellent choice. The cells displayed the desired differentiation potential and contributed to tissue repair.
10 Feb 2023
Ease of use
After sales services
Value for money
Write your own review
- You May Also Need
Description: The HeLa 382 cell line is a subclone of the cell line HeLa. The original HeLa cell line was derived from a cervical carcinoma from a 31 year old female and the HeLa 382 cell line was transfected with pBact, expression vector under control of the human beta actin promotor, resistant to G418S. Control to HeLa 422 and HeLa 432.
Description: The HeLa 422 cell line is a subclone of the cell line HeLa. The original HeLa cell line was derived from a cervical carcinoma from a 31 year old female and the HeLa 422 cell line was transfected with ER-pBact, human estrogen receptor cDNA, under control of the human beta actin promotor, resistant to G418S.;
Description: Transfected with the exon 4 defective variant of ER-pBact cDNA, human estrogen receptor cDNA, under control of the human beta actin promotor, resistant to G418S.
Species: human, Black female 31 years old
Tissue: cervix
Tumor: carcinoma, epitheloid
Original line: HeLa
Description: These cells were cloned from the GIRARDI HEART cell line (passage #623) in 1981 and were thought to "represent human heart cells"; however, isoenzyme analysis (Nelson-Rees et al., Science 191: 96-97, 1976) and DNA fingerprinting at the Creative Bioarray established unequivocally that this cell line must be considered de facto a subclone of HELA; cells were described to be sensitive to various toxins and hormones
Description: These cells were cloned from the GIRARDI HEART cell line (passage #623) in 1981 and were thought to "represent human heart cells"; however, isoenzyme analysis (Nelson-Rees et al., Science 191: 96-97, 1976) and DNA fingerprinting at the Creative Bioarray established unequivocally that this cell line must be considered de facto a subclone of HELA; cells were described to be sensitive to various toxins and hormones
